In order to help chart the course for the next era of health and biological science information.
SOURCE: NIH Director’s Page – Read entire story here.
Related posts:
- back I am back.Anyone there?How are you? ...
- Fixing problems with cell lines Dr. Collins and NIGMS Director Dr. Jon Lorsch author an article in Science Magazine addressing cell line misidentification in research and suggesting best practices for authentication and verification. Science Magazine. December 19, 2014. ...
- Appointment of Dr. Carrie Wolinetz as Associate Director for Science Policy, NIH This appointment is effective February 23, 2015. ...
- F.B.I. Investigates Whether Harm From Surgical Power Tool Was Ignored A doctor confirmed that the F.B.I. has spoken to him about morcellators, power tools that can slice tissue into tiny pieces for easier removal, but could also scatter undetected cancer cells. ...
- ONT-380 has stage IV HER2+ breast cancer patient ‘worrying about normal stuff again’ Promising clinical trial results show activity of the investigational anti-cancer agent ONT-380 against HER2+ breast cancer, in one case specifically against brain metastases and in another case in overall survival of heavily pretreated HER2+ breast cancer patients. ...
